Effect of clinical doses of buserelin on in vivo bovine uterine activity at estrus

For successful fertilization, a transfer system named “rapid sperm transport” generated by uterine contractions plays a crucial role. The purpose of this in vivo study was to investigate the effect of buserelin, a GnRH agonist widely used for ovulation induction after mating or artificial insemination, on bovine uterine contractility which supports rapid sperm transport at estrus. In vivo uterine contractile activity was measured by intrauterine pressure recording technique. In the study, the spontaneous uterine contractile activities of 28 cows at estrus were observed for 30 min. The cows were randomly divided into 4 treatment groups which have 7 cows each of and were injected appropriate agents as follows; two different clinical doses of buserelin (10.5 µg, 21 µg), oxytocin (50 IU) and control (placebo). Following treatment, drug-induced uterine activity was measured for 60 min. There were no differences in terms of frequency in all groups observed. Oxytocin which is known as an effective uterotonic increased the amplitude and area under curve of contraction at estrus. Two different doses of buserelin were observed to have no effect on uterine contractile activity in cows throughout 60 min. It was concluded that GnRH has no function on bovine uterine contractility which plays a role in sperm transportation at estrus.

PDF

___

1. Kölle S. Transport, distrubition and elimination of mammalian sperm following natural mating and insemination. Reproduction in Domestic Animals 2015; 50 (3): 2-6. doi: 10.1111/rda.12576
2. Ruckebusch Y, Bayard F. Motility of the oviduct and uterus of the cow during the oestrous cycle. Journal of Reproduction and Fertility 1975; 43 (1): 23-32. doi: 10.1530/jrf.0.0430023.
3. Al-Eknah MM, Noakes DE. Uterine activity in cows during the oestrous cycle, after ovariectomy and following exogenous oestradiol and progesterone. The British Veterinary Journal 1989; 145 (4): 328-336. doi: 10.1016/0007-1935(89)90030-4
4. Rodriguez-Martinez H, McKenna D, Weston PG, Whitmore HL, Gustafsson BK. Uterine motiliy in the cow during the estrous cycle, I. Spontaneous activity. Theriogenology 1987; 27 (2): 337-348. doi: 10.1016/0093-691x(87)90222-6
5. Suarez SS, Pacey AA. Sperm transport in the female reproductive tract. Human Reproduction Update 2006; 12 (1): 23–37. doi:10.1093/humupd/dmi047
6. Egarter CH, Husslein P. Biochemistry of myometrial contractility. Bailliére’s Clinical Obstetrics and Gynaecology 1992; 6 (4): 755-769. doi: 10.1016/s0950-3552(05)80187-7
7. Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledée N, et al. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertility and Sterility 2001; 75 (6): 1136-1140. doi: 10.1016/s0015- 0282(01)01787-3
8. Garfield RE, Shi L, Shi SQ. Use of progesterone and progestin analogs for inhibition of preterm birth and other uterine contractility disorders. Facts, Views & Vision in ObGyn 2012; 4 (4): 237-244.
9. Shemesh M. Actions of gonadotrophins on the uterus, Reproduction 2001; 121 (6): 835-842. doi: 10.1530/ rep.0.1210835
10. Shemesh M, Mizrachi D, Gurevich M, Stram Y, Shore LS, et al. Functional importance of bovine uterine and vascular LH receptors and cervical FSH receptors. Seminars in Reproductive Medicine 2001; 19 (1): 87–96. doi: 10.1055/s-2001-13915.
11. Hirsbrunner G, Eicher R, Küpfer U, Burkhardt H, Steiner A. Effect of different doses of prostaglandin E2 on intrauterine pressure and uterine motility during diestrus in experimental cows. Theriogenology 2000; 54 (2): 291-303. doi: 10.1016/ s0093-691x(00)00349-6.
12. Hirsbrunner G, Knutti B, Küpfer U, Burkhardt H, Steiner A. Effect of prostaglandin E2, DL-cloprostenol, and prostaglandin E2 in combination with D-cloprostenol on uterine motility during diestrus in experimental cows. Animal Reproduction Science 2003; 79 (1-2): 17-32. doi: 10.1016/ s0378-4320(03)00085-x
13. Adler M, Bleul U. Effect of carbetocin, oxytocin and prostaglandin E2 and F2α on intrauterine pressure in cows in dioestrus and oestrus. Tierarztliche Praxis Ausgabe G Grosstiere Nutztiere 2015; 43 (1): 15-24. doi: 10.15653/TPG140341
14. Rodriguez-Martinez H, McKenna D, Weston PG, Gustafsson BK, Whitmore H L. Uterine motility in the cow during the estrous cycle. III. Effects of oxytocin, xylazine and adrenoceptor blockers. Theriogenology 1987; 27 (2): 359-368. doi: 10.1016/0093-691x(87)90224-x
15. Giammarino A, Manera M, Robbe D, Perugini M, Amorena M. The effect of GnRH on in vitro bovine myometrial activity. Animal Reproduction Science 2009; 112 (3-4): 325-333. doi: 10.1016/j.anireprosci.2008.05.011
16. Manera M, Robbe D, Grotta L, Demontis MP, Giammarino A. Evaluation of in vitro GnRH effects on spontaneous contractions of the bovine myometrium. Veterinary Research Communications 2009; 33 (1): 193-16. doi: 10.1007/s11259- 009-9276-6
17. Medeiros YS, Calixto JB, Ballejo G. Inhibitory effect of GnRH on isolated rat uterine muscle contractility. Life Sciences 1998; 42 (21): 2055-2062. doi: 10.1016/0024-3205(88)90118-x
18. Clarke IJ, Pompolo S. Synthesis and secretion of GnRH. Animal Reproduction Science 2005; 88 (1-2): 29-55. doi: 10.1016/j. anireprosci.2005.05.003
19. Ramakrishnappa N, Rajamahendran R, Yung-Ming L, Leung PCK. GnRH in non-hypothalamic reproductive tissues. Animal Reproduction Science 2005; 88 (1-2): 95-113. doi: 10.1016/j.anireprosci.2005.05.009
20. Singh R, Graves ML, Roskelley CD, Giritharan G, Rajamahendran R. Gonadotropin releasing hormone receptor gene and protein expression and immunohistochemical localization in bovine uterus and oviducts. Domestic Animal Endocrinology 2008; 34 (3): 319-326. doi: 10.1016/j. domaniend.2007.09.004
21. Rizzo A, Campanile D, Mutinati M, Minoia G, Spedicato M, et al. Epidural vs intramuscular administration of lecirelin, a GnRH analogue, for the resolution of follicular cysts in dairy cows. Animal Reproduction Science 2011; 126 (1-2): 19-22. doi: 10.1016/j.anireprosci.2011.04.013
22. Schäfer-Somi S, Kowalewski MP, Kanca H, Bozkurt MF, Gram A, et al. GnRH and its receptor (GnRH-R) are expressed in the canine placenta and uterus. Theriogenology 2015; 84 (9): 1482- 1489. doi: 10.1016/j.theriogenology.2015.07.034
23. Aguilar HN, Mitchell BF. Physiological pathways and molecular mechanisms regulating uterine contractility. Human Reproduction Update 2010; 16 (6): 725–744. doi: 10.1093/ humupd/dmq01
24. Roelofs J, Lopez-Gatius F, Hunter RHF, Van Eerdenburg FJCM, Hanzen C. When is a cow in estrus? Clinical and practical aspects. Theriogenology 2010; 74 (3): 327-344. doi: 10.1016/j. theriogenology.2010.02.016
25. Bajcsy ÁC, Szenci O, van der Weijden GC, Doornenbal A, Maassen F, et al. The effect of a single oxytocin or carbetocin treatment on uterine contractility in early postpartum dairy cows. Theriogenology 2006; 65 (2): 400-414. doi: 10.1016/j. theriogenology.2005.05.040
26. Peters AR. Veterinary clinical application of GnRH-questions of efficacy. Animal Reproduction Science 2005; 88 (1-2): 155- 167. doi: 10.1016/j.anireprosci.2005.05.008
27. Cooper MD, Foote RH. Effect of oxytocin, prostaglandin F2 aplha and reproductive tract manipulations on uterine contractility in Holstein cows on days 0 and 7 of the estrous cycle. Journal of Animal Science 1986; 63 (1): 151-161. doi: 10.2527/jas1986.631151x
28. Chenault JR, Kratzer DD, Rzepkowski RA, Goodwin MC. LH and FSH response of Holstein heifers to fertirelin acetate, gonadorelin and buserelin. Theriogenology 1990; 34 (1): 81-98. doi: 10.1016/0093-691x(90)90579-i
29. Padula AM. GnRH analogues-agonists and antagonists. Animal Reproduction Science 2005; 88 (1-2): 115-126. doi: 10.1016/j.anireprosci.2005.05.005
30. Picard-Hagen N, Lhermie G, Florentin S, Merle D, Frein P, et al. Effect of gonadorelin, lecirelin, and buserelin on LH surge, ovulation, and progesterone in cattle. Theriogenology 2015; 84 (2): 177-183. doi: 10.1016/j.theriogenology.2015.03.004
31. Bajcsy ÁC. Physiological and clinical aspects of uterine contractility during the postpartum period in cows. PhD, Utrecht University, Utrecht, Netherlands, 2005.